Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

Experiencing fatigue, blurred vision, and unexplained weight loss, a young man sought medical consultation and was informed ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...

Diabetic retinopathy is a serious concern for people dealing with diabetes. Detecting diabetic retinopathy poses significant challenges, requiring skilled professionals, extensive manual image ...

Greg Ellwood-Hughes explores how AI is supporting ophthalmology services and the issues to be addressed in the coming years ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and ...

Diabetic retinopathy is the leading cause of blindness in ... In December 2024, the trial completed randomization of more than 300 evaluable treatment-naïve subjects with a diagnosis of wet AMD in the ...